Healthy men help uncover drug interactions in Early-Stage trial

NCT ID NCT06070610

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study looked at how taking multiple doses of an experimental drug (BI 1015550) changes the way the body handles two approved lung medications (nintedanib and pirfenidone). Fourteen healthy men received the drugs in a fixed order, and researchers measured drug levels in their blood. The goal was to see if BI 1015550 speeds up or slows down the breakdown of these medicines, which helps guide future dosing in patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Humanpharmakologisches Zentrum Biberach

    Biberach, 88397, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.